Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedAdded Schizophrenia to the glossary/related terms and included MedlinePlus Genetics as a related topic; updated the site revision from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe content now omits the 'Schizophrenia' condition label, the 'related topics:' header, and the 'MedlinePlus Genetics' link, reducing visible context about the study condition and related health information.SummaryDifference0.0%

- Check20 days agoChange DetectedNew quick-access navigation items were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was updated; the page now shows an updated Revision tag (Revision: v3.6.0).SummaryDifference0.2%

- Check27 days agoChange DetectedThe Revision line on the page was updated from v3.5.4 to v3.5.5, representing a small update to the page revision.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's related topics now include Schizophrenia and MedlinePlus Genetics, and the revision tag was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check56 days agoChange DetectedSchizophrenia, related topics, and MedlinePlus Genetics references were removed from the page, changing how the study’s condition and related educational resources are presented to users. This affects the contextual framing of the trial without altering the underlying data.SummaryDifference0.0%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.